Table 3.
Estimated total annual costs and effects of cervical screening in Australia, excluding overheads (all costs in Australian dollars)
| Annual costs to health care system | Direct cytology cost component | Discounted lifetime cost (5% discount rate) |
Discounted life-years (5% discount rate) |
Cost-effectiveness ratio compared to no intervention | |
|---|---|---|---|---|---|
| No intervention | $34.7M* | - | $52.1* | 18.8619 | - |
|
Current practice, 2-yearly recommendation |
$166.7M | $37.4 M (22%) | $416.7 | 18.8723 | $35,000/LYS |
|
Continue reminder system, 3-yearly recommendation |
$156.7M | $34.4 M (22%) | $396.4 | 18.8723 | $33,000/LYS |
|
Call-and-recall, 3-yearly recommendation |
$148.8M | $32.3 (22%) | $373.8 | 18.8723 | $31,000/LYS |
*Estimated cost of cervical cancer treatment in an unscreened population